Inflammaging and Immunosenescence: Mechanisms and Link
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 734
Special Issue Editor
Special Issue Information
Dear Colleagues,
Inflammaging represents chronic, sterile, low-grade inflammation during aging and in age-related diseases. These age-related diseases may include osteoarthritis, sarcopenia, polyarthritis, metabolic syndrome, diabetic mellitus, neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease, cardiovascular disease, cancer, chronic obstructive pulmonary disease, and chronic kidney disease. The contribution of inflammaging during aging is gradually widely known, but in age-related diseases, this puzzle must be solved.
Another character of aging and age-related disease is immunosenescence, or aging immunity. Immunosenescence has been widely studied in cancer, chronic kidney disease, and autoimmune disease. However, the role of immunosenescence in a other age-related disease remained to be elucidated.
Authors are invited to submit manuscripts discussing inflammaging or immunosenescence, focusing either on the basic or translational aspects, particularly related to autoimmunity and age-related diseases. The Special Issue welcomes up-to-date comprehensive reviews and research articles. Clinical studies combined with molecular research, if relevant, as well as computational modeling, are also welcome.
Dr. Chieh Yu Shen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammaging
- immunosenescence
- autoimmune disease
- age-related disease
- aging
